Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FELQA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,231
Award facts
- Contract value 100% obligated
- $24,231.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,231.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, was made without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. will supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR and valued at $499,999,999. The PPV-G GEN V program represents a $30.3 billion acquisition strategy establishing multiple regional prime vendor contractors to provide comprehensive pharmaceutical supply support, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to military healthcare facilities worldwide. The underlying indefinite delivery contract, awarded on November 13, 2025, extends through December 31, 2036, with a 30-month base period and three 30-month option periods, positioning DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DU26FELQA?
SPE2DU26FELQA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DU26FELQA worth?
The government has obligated $24,231 on SPE2DU26FELQA.
Is contract SPE2DU26FELQA an order under another contract?
Yes. SPE2DU26FELQA is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELQA competed?
The extent of competition for SPE2DU26FELQA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award